biospecimen__admin__batch_number	425.45.0
biospecimen__admin__bcr	Nationwide Children's Hospital
biospecimen__admin__day_of_dcc_upload	1
biospecimen__admin__disease_code	LIHC
biospecimen__admin__file_uuid	B4FBE9AA-D33F-4DCD-ABD1-0CCC6788C7B7
biospecimen__admin__month_of_dcc_upload	7
biospecimen__admin__year_of_dcc_upload	2016
biospecimen__bio__bcr_analyte_barcode	TCGA-5R-AA1C-01A-11R
biospecimen__bio__bcr_portion_barcode	TCGA-5R-AA1C-01A-11
biospecimen__bio__bcr_sample_barcode	TCGA-5R-AA1C-01A
biospecimen__bio__biospecimen_barcode_bottom	0174164351
biospecimen__bio__day_of_creation	25
biospecimen__bio__day_of_shipment	28
biospecimen__bio__days_to_index	0
biospecimen__bio__gel_image_file	https://sharedoc.nchri.org/tcga-bcr/default.aspx
biospecimen__bio__is_derived_from_ffpe	NO
biospecimen__bio__month_of_creation	02
biospecimen__bio__month_of_shipment	05
biospecimen__bio__pathology_report_file_name	TCGA-5R-AA1C.AF0BACCE-3975-4E9F-9272-404229EC77C9.pdf
biospecimen__bio__plate_column	1
biospecimen__bio__plate_id	A41H
biospecimen__bio__plate_row	A
biospecimen__bio__quantity	3.20
biospecimen__bio__subportion_sequence	1
biospecimen__bio__vial_number	A
biospecimen__bio__volume	20.00
biospecimen__bio__year_of_creation	2014
biospecimen__bio__year_of_shipment	2014
biospecimen__shared__bcr_patient_barcode	TCGA-5R-AA1C
biospecimen__shared__patient_id	AA1C
clinical__admin__day_of_dcc_upload	22
clinical__admin__file_uuid	74127A60-2212-47FF-B331-897F92BE2A08
clinical__admin__month_of_dcc_upload	12
clinical__admin__withdrawn	false
clinical__chol_lihc_shared__albumin_result_lower_limit	3.2
clinical__chol_lihc_shared__albumin_result_specified_value	3.0
clinical__chol_lihc_shared__albumin_result_upper_limit	4.6
clinical__chol_lihc_shared__bilirubin_lower_limit	0
clinical__chol_lihc_shared__bilirubin_upper_limit	1.8
clinical__chol_lihc_shared__child_pugh_classification_grade	B
clinical__chol_lihc_shared__creatinine_lower_level	0.5
clinical__chol_lihc_shared__creatinine_upper_limit	1.3
clinical__chol_lihc_shared__creatinine_value_in_mg_dl	1.0
clinical__chol_lihc_shared__fetoprotein_outcome_lower_limit	0
clinical__chol_lihc_shared__fetoprotein_outcome_upper_limit	15
clinical__chol_lihc_shared__fetoprotein_outcome_value	2
clinical__chol_lihc_shared__fibrosis_ishak_score	1,2 - Portal Fibrosis
clinical__chol_lihc_shared__hist_hepato_carc_fact	No History of Primary Risk Factors
clinical__chol_lihc_shared__inter_norm_ratio_lower_limit	11
clinical__chol_lihc_shared__intern_norm_ratio_upper_limit	15
clinical__chol_lihc_shared__platelet_result_lower_limit	150000
clinical__chol_lihc_shared__platelet_result_upper_limit	450000
clinical__chol_lihc_shared__prothrombin_time_result_value	18
clinical__chol_lihc_shared__specimen_collection_method_name	Extended Lobectomy
clinical__chol_lihc_shared__total_bilirubin_upper_limit	1.2
clinical__chol_lihc_shared__vascular_tumor_cell_type	Micro
clinical__clin_shared__age_at_initial_pathologic_diagnosis	57
clinical__clin_shared__bcr_followup_barcode	TCGA-5R-AA1C-F68309
clinical__clin_shared__bcr_followup_uuid	4617D528-C984-4971-A6B3-F54E515F554F
clinical__clin_shared__day_of_form_completion	14
clinical__clin_shared__days_to_initial_pathologic_diagnosis	0
clinical__clin_shared__eastern_cancer_oncology_group	1
clinical__clin_shared__informed_consent_verified	YES
clinical__clin_shared__lost_follow_up	NO
clinical__clin_shared__month_of_form_completion	11
clinical__clin_shared__platelet_result_count	223000
clinical__clin_shared__post_op_ablation_embolization_tx	NO
clinical__clin_shared__postoperative_rx_tx	NO
clinical__clin_shared__radiation_therapy	NO
clinical__clin_shared__relative_family_cancer_history	NO
clinical__clin_shared__residual_tumor	R0
clinical__clin_shared__tissue_prospective_collection_indicator	YES
clinical__clin_shared__tissue_retrospective_collection_indicator	NO
clinical__clin_shared__tumor_tissue_site	Liver
clinical__clin_shared__viral_hepatitis_serology	Hepatitis  C Antibody
clinical__clin_shared__year_of_form_completion	2015
clinical__clin_shared__year_of_initial_pathologic_diagnosis	2013
clinical__lihc__adjacent_hepatic_tissue_inflammation_extent_type	None
clinical__nte__new_tumor_event_after_initial_treatment	NO
clinical__shared__histological_type	Hepatocellular Carcinoma
clinical__shared__history_of_neoadjuvant_treatment	No
clinical__shared__neoplasm_histologic_grade	G2
clinical__shared__other_dx	No
clinical__shared_stage__pathologic_m	M0
clinical__shared_stage__pathologic_n	N0
clinical__shared_stage__pathologic_t	T2
clinical__shared_stage__system_version	7th
gdc__access	open
gdc__acl	open
gdc__aliquots__aliquot_id	ef83c3dc-2b50-40ec-a313-cc7c79bf5a9b
gdc__aliquots__concentration	0.16
gdc__aliquots__source_center	23
gdc__aliquots__submitter_id	TCGA-5R-AA1C-01A-11R-A41H-13
gdc__aliquots__updated_datetime	2018-09-06T14:13:07.098771-05:00
gdc__analysis__analysis_id	3cb8390e-bf10-4359-9532-95c2034289a6
gdc__analysis__workflow_link	https://github.com/NCI-GDC/gdc-dnaseq-cwl/blob/gdc-active-submission/workflows/mirnaseq/runner.cwl
gdc__analysis__workflow_type	BCGSC miRNA Profiling
gdc__analytes__a260_a280_ratio	1.86
gdc__analytes__analyte_id	61efb661-7622-44d9-a113-982fe7d62ac3
gdc__analytes__analyte_type	RNA
gdc__analytes__analyte_type_id	R
gdc__analytes__spectrophotometer_method	UV Spec
gdc__case_id	290890eb-321c-45dc-9cd1-45676c6e5e96
gdc__center__center_id	6eba705a-0f00-5aa2-b1d0-04dbf62100cc
gdc__center__center_type	CGCC
gdc__center__code	13
gdc__center__name	Canada's Michael Smith Genome Sciences Centre
gdc__center__namespace	bcgsc.ca
gdc__center__short_name	BCGSC
gdc__created_datetime	2018-03-20T12:29:32.212662-05:00
gdc__data_category	Transcriptome Profiling
gdc__data_format	TXT
gdc__data_type	miRNA Expression Quantification
gdc__demographic__demographic_id	6dbba301-dffd-51a0-9396-c9780c442b3a
gdc__demographic__ethnicity	not hispanic or latino
gdc__demographic__gender	male
gdc__demographic__race	white
gdc__demographic__year_of_birth	1956
gdc__diagnoses__age_at_diagnosis	21073
gdc__diagnoses__classification_of_tumor	not reported
gdc__diagnoses__days_to_birth	-21073.0
gdc__diagnoses__days_to_last_follow_up	520.0
gdc__diagnoses__diagnosis_id	1c828ed7-ce0f-5d67-aa9f-a7d0e56fbfe3
gdc__diagnoses__last_known_disease_status	not reported
gdc__diagnoses__morphology	8170/3
gdc__diagnoses__primary_diagnosis	Hepatocellular carcinoma NOS
gdc__diagnoses__prior_malignancy	not reported
gdc__diagnoses__progression_or_recurrence	not reported
gdc__diagnoses__site_of_resection_or_biopsy	Liver
gdc__diagnoses__tissue_or_organ_of_origin	Liver
gdc__diagnoses__tumor_grade	not reported
gdc__diagnoses__tumor_stage	stage ii
gdc__diagnoses__vital_status	alive
gdc__disease_type	Adenomas and Adenocarcinomas
gdc__experimental_strategy	miRNA-Seq
gdc__exposures__bmi	29.72651605231867
gdc__exposures__exposure_id	c2819272-d77c-5300-9d26-07da83c505aa
gdc__exposures__height	174.0
gdc__exposures__weight	90.0
gdc__file_id	64558d7b-8157-42c5-a7ee-722736ee9a32
gdc__file_name	667d4cd7-8532-41e8-a66c-1da3740604f4.mirbase21.mirnas.quantification.txt
gdc__file_size	50228
gdc__input_files__data_category	Raw Sequencing Data
gdc__input_files__data_format	BAM
gdc__input_files__data_type	Aligned Reads
gdc__input_files__experimental_strategy	miRNA-Seq
gdc__input_files__platform	Illumina
gdc__md5sum	1935bec7f4b12b70b1228d01239392ac
gdc__portions__is_ffpe	false
gdc__portions__portion_id	3bcb0a0a-a24f-45bc-bb9a-cc4db716ba89
gdc__portions__portion_number	11
gdc__portions__weight	30.0
gdc__primary_site	Liver and intrahepatic bile ducts
gdc__program__dbgap_accession_number	phs000178
gdc__program__name	TCGA
gdc__program__program_id	b80aa962-9650-5110-b3eb-bd087da808db
gdc__project__disease_type	Liver Hepatocellular Carcinoma
gdc__project__primary_site	Liver
gdc__project__project_id	TCGA-LIHC
gdc__project__releasable	false
gdc__project__released	true
gdc__samples__days_to_collection	60
gdc__samples__initial_weight	750.0
gdc__samples__oct_embedded	false
gdc__samples__pathology_report_uuid	AF0BACCE-3975-4E9F-9272-404229EC77C9
gdc__samples__sample_id	59c12b57-2eea-4f8b-bbd7-6e504c1034d6
gdc__samples__sample_type	Primary Tumor
gdc__samples__sample_type_id	01
gdc__slides__percent_lymphocyte_infiltration	2.0
gdc__slides__percent_monocyte_infiltration	0.0
gdc__slides__percent_necrosis	2.0
gdc__slides__percent_neutrophil_infiltration	0.0
gdc__slides__percent_normal_cells	0.0
gdc__slides__percent_stromal_cells	4.0
gdc__slides__percent_tumor_cells	94.0
gdc__slides__percent_tumor_nuclei	96.0
gdc__slides__section_location	TOP
gdc__slides__slide_id	2d36a285-8813-4c30-b5be-fb3f5b49810d
gdc__submitter_id	mirna_swap_dr11_42_MirnaExpression11efff51-ca0e-4251-837c-6b991baef413_profiling
gdc__tissue_source_site__bcr_id	NCH
gdc__tissue_source_site__code	5R
gdc__tissue_source_site__name	Proteogenex Inc
gdc__tissue_source_site__tissue_source_site_id	9a7a9c39-f289-5594-972a-ff9157a187f0
gdc__treatments__treatment_id	96792a7f-d28a-54dc-9b12-e0fa68c48a6a
gdc__type	mirna_expression
gdc__updated_datetime	2018-09-08T13:43:34.032262+00:00
manually_curated__data_format	BED
manually_curated__download_date	2018-11-06T09:11:55.214+01:00
manually_curated__exp_data_bed_url	ftp://bioinformatics.iasi.cnr.it/opengdc/bed/tcga/tcga-lihc/mirna_expression_quantification/ef83c3dc-2b50-40ec-a313-cc7c79bf5a9b-meq.bed
manually_curated__exp_metadata_url	ftp://bioinformatics.iasi.cnr.it/opengdc/bed/tcga/tcga-lihc/mirna_expression_quantification/ef83c3dc-2b50-40ec-a313-cc7c79bf5a9b-meq.bed.meta
manually_curated__genome_built	GRCh38
manually_curated__local_file_size	129599
manually_curated__local_md5	0331b57466b3357e58f1b39c85742790
manually_curated__opengdc_download_date	2018-10-16T17:11:45.000682+02:00
manually_curated__opengdc_file_md5	5d984b8abec2f6ec09be3d7835d7bcfc
manually_curated__opengdc_file_size	50227
manually_curated__opengdc_id	ef83c3dc-2b50-40ec-a313-cc7c79bf5a9b-meq
manually_curated__origin_file_size	129599
manually_curated__origin_last_modified_date	Tue Oct 16 17:25:00 CEST 2018
manually_curated__origin_md5	0331b57466b3357e58f1b39c85742790
manually_curated__tissue_status	tumoral
